Friday, May 24, 2019
Home Authors Posts by Editor / Curator

Editor / Curator

69 POSTS 0 COMMENTS
BDC

Former Tesla Foundation Vice Chairman Joins StHealth BDC.

Editor / Curator -
Biotech News

Hercules BDC (HTGC) $13, to Present at FB Riley.

Editor / Curator -
Biotech News

Innovus (INNV) in Silicon Review Interview.

Editor / Curator -
internet stock review
Conference Calls

Innovus (INNV) Conference Call Transcript.

Editor / Curator -
Biotech News

Vaccinex (VCNX) Reports First Quarter 2019 Financial Results and Provides Corporate...

Editor / Curator -
internet stock review
Conference Calls

Innovus (INNV) Conference Call Today 5/15/19 at 4:15 EST.

Editor / Curator -
biotech stock review, fluticare
Biotech News

Innovus (INNV): Twenty-Eight Drugs in Five Years. (San Diego Reader)

Editor / Curator -
internet stock review, beyonce, uber
Internet News

Beyonce Tells Uber “Pay me in Stock!”

Editor / Curator -
biotech stock review, innovus
Biotech News

Adding Innovus Pharma (INNV) $2.50 to Watch List.

Editor / Curator -
biotech stock review, zestra
Biotech News

Innovus Pharma (INNV) Partners With Lavasta’s 150 Member Sales Force for...

Editor / Curator -
123...7Page 1 of 7

Stay connected

15,320FansLike
1,497FollowersFollow
11,182SubscribersSubscribe

Latest article

Former Tesla Foundation Vice Chairman Joins StHealth BDC.

BDC Editor / Curator -
St Health Capital Investment Corporation is delighted to announce Dr. Robert GW Brown FAPS, FIEE, FInstP, MAE as a key new member to our board...

Hercules BDC (HTGC) $13, to Present at FB Riley.

Biotech News Editor / Curator -
Hercules Capital to Discuss 2019 Growth Opportunities at the B. Riley FBR Institutional Investor Conference PALO ALTO, Calif.--(BUSINESS...

Innovus (INNV) in Silicon Review Interview.

Biotech News Editor / Curator -
POISED FOR INNOVATION. The Silicon Review is the world’s most trusted online and print community for business &...
The Internet Stock Review is one of Wall Streets oldest newsletters covering internet technology having launched in 1999. The Biotech Stock Review is rather old too, having launched in 2002. We make our money by purchasing stock with our services, so the better our client stocks do, the better we all do. And when we're wrong, we feel the pain too! See our research reports for important disclaimer details. Content is provided by Institutional Analyst Inc., the website is managed by Revelers.IO Media Group Inc. To see if your Company qualifies for coverage, call 310-594-8062
Contact us: roland@institutionalanalyst.com
© Managed by Revelers.IO Media Group Inc.